Biomerica (BMRA) Capital Expenditures (2010 - 2024)

Biomerica (BMRA) has 15 years of Capital Expenditures data on file, last reported at $24000.0 in Q2 2024.

• For the quarter ending Q2 2024, Capital Expenditures changed N/A year-over-year to $24000.0; the trailing twelve-month figure through May 2024 stood at $51000.0 (down 20.31% YoY), and the FY2024 full-year result was $51000.0, down 20.31% from the prior year.
• Capital Expenditures grew to $24000.0 in Q2 2024, from $6000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $45194.0 in Q1 2021 to a low of $5141.0 in Q3 2021.
• A 5-year average of $20946.3 and a median of $21689.5 in 2020 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures soared 1723.49% in 2020 and slumped 87.01% in 2021, its largest moves.
• Tracing BMRA's Capital Expenditures over 5 years: stood at $21978.0 in 2020, then slumped by 40.53% to $13071.0 in 2021, then surged by 83.61% to $24000.0 in 2022, then tumbled by 75.0% to $6000.0 in 2023, then jumped by 300.0% to $24000.0 in 2024.
• Business Quant data shows BMRA's Capital Expenditures at $24000.0 in Q2 2024, $6000.0 in Q4 2023, and $21000.0 in Q3 2023.